A comparative analysis and systematic review of the wound-healing milieu: Implications for body contouring after massive weight loss

Plastic and Reconstructive Surgery

Volumn 124, Issue 5, 2009, Pages 1675-1682

  Albino, Frank P ^a,b   Koltz, Peter F ^a,b   Gusenoff, Jeffrey A ^a,b  

^a Division of Plastic Surgery   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARIATRIC SURGERY; BIOLOGICAL MARKERS; BURNS; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; NEOPLASMS; OBESITY; ORGAN TRANSPLANTATION; RECONSTRUCTIVE SURGICAL PROCEDURES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WEIGHT LOSS; WOUND HEALING;

EID: 73549102445     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181b98bb4     Document Type: Article

References (66)

1. Agha-Mohammadi S, Hurwitz DJ. Potential impacts of nutritional deficiency of postbariatric patients on body contouring surgery. Plast Reconstr Surg. 2008;122:1901-1914.
2. Tice JA, Karliner L, Walsh J, Petersen AJ, Feldman MD. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med. 2008; 121:885-893.
3. Gusenoff JA, Coon D, Rubin JP. Implications of weight loss method in body contouring outcomes. Plast Reconstr Surg. 2009;123:373-376.
4. Wolf AM, Kuhlmann HW. Reconstructive procedures after massive weight loss. Obes Surg. 2007;17:355-360.
5. Coon D, Gusenoff JA, Kannan N, El Khoudary SR, Naghshineh N, Rubin JP. Body mass and surgical complications in the postbariatric reconstructive patient: Analysis of 511 cases. Ann Surg. 2009;249:397-401.
6. Chen WY, Rogers AA, Lydon MJ. Characterization of biologic properties of wound fluid collected during early stages of wound healing. J Invest Dermatol. 1992;99:559-564.
7. Vaalamo M, Leivo T, Saarialho-Kere U. Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum Pathol. 1999;30:795-802.
8. Trengove NJ, Stacey MC, MacAuley S, et al. Analysis of the acute and chronic wound environments: The role of proteases and their inhibitors. Wound Repair Regen. 1999;7:442-452.
9. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999;341:738-746.
10. O'Kane S, Ferguson MW. Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol. 1997;29:63-78.
11. Ruvalcaba-Limon E, Robles-Vidal C, Poitevin-Chacon A, Chávez-Macgregor M, Gamboa-Vignolle C, Vilar-Compte D. Complications after breast cancer surgery in patients treated with concomitant preoperative chemoradiation: A case-control analysis. Breast Cancer Res Treat. 2006;95:147-152.
12. Murthy BL, Thomson CS, Dodwell D, et al. Postoperative wound complications and systemic recurrence in breast cancer. Br J Cancer 2007;97:1211-1217.
13. Sorensen LT, Horby J, Friis E, Pilsgaard B, Jørgensen T. Smoking as a risk factor for wound healing and infection in breast cancer surgery. Eur J Surg Oncol. 2002;28:815-820.
14. Kolb BA, Buller RE, Connor JP, DiSaia PJ, Berman ML. Effects of early postoperative chemotherapy on wound healing. Obstet Gynecol. 1992;79:988-992.
15. Hemington-Gorse S, Pellard S, Wilson-Jones N, Potokar T. Foot burns: Epidemiology and management. Burns 2007;33: 1041-1045.
16. Mayhall CG. The epidemiology of burn wound infections: Then and now. Clin Infect Dis. 2003;37:543-550.
17. Knight RJ, Villa M, Laskey R, et al. Risk factors for impaired wound healing in sirolimus-treated renal transplant recipients. Clin Transplant. 2007;21:460-465.
18. Troppmann C, Pierce JL, Gandhi MM, Gallay BJ, McVicar JP, Perez RV. Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: A matched-pair pilot study. Transplantation 2003;76:426-429.
19. Valente JF, Hricik D, Weigel K, et al. Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation. Am J Transplant. 2003;3:1128-1134.
20. Gamboa-Bobadilla GM, Killingsworth C. Large-volume reduction mammaplasty: The effect of body mass index on postoperative complications. Ann Plast Surg. 2007;58:246-249.
21. Momeni A, Heier M, Bannasch H, Stark GB. Complications in abdominoplasty: A risk factor analysis. J Plast Reconstr Aesthet Surg. 2009;62:1250-1254.
22. Heller JB, Teng E, Knoll B, Persing J. Outcome analysis of combined lipoabdominoplasty versus conventional abdominoplasty. Plast Reconstr Surg. 2008;121:1821-1829.
23. Garvey PB, Buchel EW, Pockaj BA, Gray RJ, Samson TD. The deep inferior epigastric perforator flap for breast reconstruction in overweight and obese patients. Plast Reconstr Surg. 2005;115:447-457.
24. Singer AJ, McClain SA. Persistent wound infection delays epidermal maturation and increases scarring in thermal burns. Wound Repair Regen. 2002;10:372-377.
25. Neaman KC, Hansen JE. Analysis of complications from abdominoplasty: A review of 206 cases at a university hospital. Plast Reconstr Surg. 2007;58:292-298.
26. Podnos YD, Jimenez JC, Wilson SE, Stevens CM, Nguyen NT. Complications after laparoscopic gastric bypass. Arch Surg. 2003;138:957-961.
27. Loo WT, Sasano H, Chow LW. Pro-inflammatory cytokine, matrix metalloproteinases and TIMP-1 are involved in wound healing after mastectomy in invasive breast cancer patients. Biomed Pharmacother. 2007;61:548-552.
28. Pardo A, Selman M. MMP-1: The elder of the family. Int J Biochem Cell Biol. 2005;37:283-288.
29. Bister VO, Salmela MT, Karjalainen-Lindsberg ML, et al. Differential expression of three matrix metalloproteinases, MMP-19, MMP-26, and MMP-28, in normal and inflamed intestine and colon cancer. Dig Dis Sci. 2004;49:653-661.
30. Iida J, McCarthy JB. Expression of collagenase-1 (MMP-1) promotes melanoma growth through the generation of active transforming growth factor-beta. Melanoma Res. 2007;17: 205-213.
31. Wolf C, Chenard MP, Durand de Grossouvre P, Bellocg JP, Chambon P, Basset P. Breast-cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing. J Invest Dermatol. 1992;99:870-872.
32. Ahokas K, Skoog T, Suomela S, et al. Matrilysin-2 (matrix metalloproteinase-26) is upregulated in keratinocytes during wound repair and early skin carcinogenesis. J Invest Dermatol. 2005;124:849-856.
33. Moore LD, Isayeva T, Siegal GP, Ponnazhagan S. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: Implications for proliferation and migration in vitro and metastasis in vivo. Clin Cancer Res. 2008;14:4961-4970.
34. Hormbrey E, Han C, Roberts A, McGrouther DA, Harris AL. The relationship of human wound vascular endothelial growth factor (VEGF) after breast cancer surgery to circulating VEGF and angiogenesis. Clin Cancer Res. 2003;9:4332-4339.
35. Komorowski J, Pasieka Z, Jankiewicz-Wika J, Stepień H. Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer. Thyroid 2002;12:655-662.
36. Neely AN, Brown RL, Clendening CE, Orloff MM, Gardner J, Greenhalgh DG. Proteolytic activity in human burn wounds. Wound Repair Regen. 1997;5:302-309.
37. Ulrich D, Noah EM, von Heimburg D, Pallua N. TIMP-1, MMP-2, MMP-9, and PIIINP as serum markers for skin fibrosis in patients following severe burn trauma. Plast Reconstr Surg. 2003;111:1423-1431.
38. Dasu MR, Spies M, Barrow RE, Herndon DN. Matrix metalloproteinases and their tissue inhibitors in severely burned children. Wound Repair Regen. 2003;11:177-180.
39. Sikora JP, Chlebna-Sokol D, Andrzejewska E, et al. Clinical evaluation of proinflammatory cytokine inhibitors (sTNFR I, sTNFR II, IL-1 ra), anti-inflammatory cytokines (IL-10, IL-13) and activation of neutrophils after burn-induced inflammation. Scand J Immunol. 2008;68:145-152.
40. Ono I, Gunji H, Zhang JZ, Maruyama K, Kaneko F. A study of cytokines in burn blister fluid related to wound healing. Burns 1995;21:352-355.
41. Chang H, Kuo W, Hsieh Y, et al. Circulating matrix metalloproteinase- 2 is associated with cystatin C level, posttransplant duration, and diabetes mellitus in kidney transplant recipients. Transl Res. 2008;151:217-223.
42. Roos N, Poulalhon N, Farge D, Madelaine I, Mauviel A, Verrecchia F. In vitro evidence for a direct antifibrotic role of the immunosuppressive drug mycophenolate mofetil. J Pharmacol Exp Ther. 2007;321:583-589.
43. Eski M, Sahin I, Sengezer M, Serdar M, Ifran A. Thalidomide decreases the plasma levels of IL-1 and TNF following burn injury: Is it a new drug for modulation of systemic inflammatory response. Burns 2008;34:104-108.
44. Cottam DR, Mattar SG, Barinas-Mitchell E, et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: Implications and effects of weight loss. Obes Surg. 2004;14:589-600.
45. Glowinska-Olszewska B, Urban M. Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents. Metabolism 2007;56:799-805.
46. Gletsu N, Lin E, Zhu J, et al. Increased plasma interleukin 6 concentrations and exaggerated adipose tissue interleukin 6 content in severely obese patients after operative trauma. Surgery 2006;140:50-57.
47. Klein S, Mittendorfer B, Eagon JC, et al. Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology 2006;130:1564-1572.
48. Lobmann R, Zemlin C, Motzkau M, Reschke K, Lehnert H. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing. J Diabetes Complications 2006;20:329-335.
49. Dalton SJ, Whiting CV, Bailey JR, Mitchell DC, Tarlton JF. Mechanisms of chronic skin ulceration linking lactate, transforming growth factor-beta, vascular endothelial growth factor, collagen remodeling, collagen stability, and defective angiogenesis. J Invest Dermatol. 2007;127:958-968.
50. Barone EJ, Yager DR, Pozez AL, et al. Interleukin-1alpha and collagenase activity are elevated in chronic wounds. Plast Reconstr Surg. 1998;102:1023-1027; discussion 1028-1029.
51. Gohel MS, Windhaber RA, Tarlton JF, Whyman MR, Poskitt KR. The relationship between cytokine concentrations and wound healing in chronic venous ulceration. J Vasc Surg. 2008;48:1272-1277.
52. Igwe D Jr, Stanczyk M, Lee H, Felahy B, Tambi J, Fobi MA. Panniculectomy adjuvant to obesity surgery. Obes Surg. 2000; 10:530-539.
53. Costa LF, Landecker A, Manta AM. Optimizing body contour in massive weight loss patients: The modified vertical abdominoplasty. Plast Reconstr Surg. 2004;114:1917-1923; discussion 1924-1926.
54. Manahan MA, Shermak MA. Massive panniculectomy after massive weight loss. Plast Reconstr Surg. 2006;117:2191-2197; discussion 2198-2199.
55. Taylor J, Shermak M. Body contouring following massive weight loss. Obes Surg. 2004;14:1080-1085.
56. Menderes A, Baytekin C, Haciyanli M, Yilmaz M. Dermalipectomy for body contouring after bariatric surgery in Aegean region of Turkey. Obes Surg. 2003;13:637-641.
57. Modolin M, Cintra W Jr, Gobbi CI, Ferreira MC. Circumferential abdominoplasty for sequential treatment after morbid obesity. Obes Surg. 2003;13:95-100.
58. Agha-Mohammadi S, Hurwitz DJ. Nutritional deficiency of post-bariatric surgery body contouring patients: What every plastic surgeon should know. Plast Reconstr Surg. 2008;122: 604-613.
59. Greco JA III, Castaldo ET, Nanney LB, et al. The effect of weight loss surgery and body mass index on wound complications after abdominal contouring operations. Ann Plast Surg. 2008;61:235-242.
60. Nemerofsky RB, Oliak DA, Capella JF. Body lift: An account of 200 consecutive cases in the massive weight loss patient. Plast Reconstr Surg. 2006;117:414-430.
61. Hurwitz DJ, Agha-Mohammadi S, Ota K, Unadkat J. A clinical review of total body lift surgery. Aesthet Surg J. 2008;3:294-303; discussion 304-305.
62. Gusenoff JA, Coon D, Rubin JP. Brachioplasty and concomitant procedures after massive weight loss: A statistical analysis from a prospective registry. Plast Reconstr Surg. 2008;122: 595-603.
63. Dalton SJ, Mitchell DC, Whiting CV, Tarlton JF. Abnormal extracellular matrix metabolism in chronically ischemic skin: A mechanism for dermal failure in leg ulcers. J Invest Dermatol. 2005;125:373-379.
64. Gmur RU, Banic A, Erni D. Is it safe to combine abdominoplasty with other dermolipectomy procedures to correct skin excess after weight loss? Ann Plast Surg. 2003;51:353-357.
65. Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med. 1996;334:1209-1215.
66. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002;45:1011-1016.